CBD-Intel

Author: Dmytro Korchahin

Regulatory report: Finland

Written by Dmytro Korchahin || 12th July 2021 || Regulatory reports |

This report provides a comprehensive overview of the current regulatory framework for hemp, CBD and cannabis in Finland, covering all areas from cultivation to finished products and import/export restrictions ...

Regulatory report: Slovakia

Written by Dmytro Korchahin || 28th April 2021 || Regulatory reports |

CBD will become legal for the first time in Slovakia on 1st May 2021. This report offers a detailed overview of the regulatory framework in the country for hemp, CBD and medical and recreational cannabis ...

Regulatory report: Netherlands

Written by Dmytro Korchahin || 15th February 2021 || Regulatory reports |

The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD ...

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions